Hopeful results with SGLT2 inhibitor in patients with T2DM and chronic kidney disease
This video was recorded at the ISN World Congress of Nephrology in Melbourne, Australia, on April 15, 2019.
Vlado Perkovic is Executive Director of The George Institute, Australia, Professor of Medicine at UNSW Sydney, and a Staff Specialist in Nephrology at the Royal North Shore Hospital. His research focus is in clinical trials and epidemiology, in particular in preventing the progression of kidney disease and its complications.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.